FCCC LOGO Faculty Publications
Fayad L , Patel H , Verhoef G , Smith MR , Johnson PWM , Czuczman MS , Coiffier B , Hess G , Gine E , Advani A , Offner F , Vandendries ER , Shapiro M , Dang NH
Safety and Clinical Activity of the Anti-CD22 Immunoconjugate Inotuzumab Ozogamicin (CMC-544) in Combination with Rituximab in Follicular Lymphoma or Diffuse Large B-Cell Lymphoma: Preliminary Report of a Phase 1/2 Study
. 2008 :105-105
PMID: ISI:000262104700267   
Back to previous list
Abstract
Notes
Fayad, Luis Patel, Hemant Verhoef, Gregor Smith, Mitchell R. Johnson, Peter W. M. Czuczman, Myron S. Coiffier, Bertrand Hess, Georg Gine, Eva Advani, Anjali Offner, Fritz Vandendries, Erik R. Shapiro, Mark Dang, Nam H. 0 389OP